Cancer Chemo- and Immunopharmacology

Tumor-Specific Antigens.- Autoreactive Cells as Mediators of the Natural Defense Against Malignant Tumors.- Progress in Experimental Systemic Active Immunotherapy of Cancer.- Host's Immune State and Kinetics of Local Tumor Growth Control - Progression of Postoperative Lung Metastasis.- Immunotherapy Versus Chemotherapy of Acute Myeloid Leukemia: Response to PHA, Allogeneic Lymphocytes, and Leukemic Myeloblasts of Remission Lymphocytes from Leukemia Patients.- Suppressor Cells in Hodgkin's Disease and Lung Carcinoma.- Immune Imbalance in Cancer Patients.- Immunorestoration of Anergic Cancer Patients by Azimexon.- BCG Versus VCN: The Antigenicity and the Adjuvant Effect of Both Compounds.- Differences in Chemotherapeutic Susceptibility of Human T-, B-, and Non-T-/Non-B-Lymphocytes in Culture.- The Significance of Lectin Receptors in the Kidney and in Hypernephroma (Renal Adenocarcinoma).- Specific Immunotherapy of Acute Lymphoid Leukemia Patients by REH Cell Line.- Results of Postoperative Treatment of Colorectal Cancer by Radiotherapy, Chemotherapy and Immunotherapy.- Some "Pharmacologic" Data About Corynebacterium Parvum.- Increased Resistance to Tumor Graft in Mice Infected by Vaccinal Strains of Brucella Abortus.- Thymosin: Basic Properties and Clinical Application in the Treatment of Immunodeficiency Diseases and Cancer.- One or Several Thymic Hormones?.- Ability of Thymosin to Decrease in Vivo and in Vitro Suppressor Cell Activity in Tumor Bearing Mice and Cancer Patients.- Screening of Small Molecular Microbial Products Modulating Immune Responses and Bestatin.- A Review of Clinical Studies of Bestatin.- Bestatin Treatment and the Peripheral Lymphocyte Population in Cancer Patients.- Correction of Immunodeficiency in Aged Mice by Levamisole and BestatinAdministration.- Therapeutic Effects of BM 12,531 (Prop. INN Azimexon).- In Vivo Immunomodulating Properties of Two Synthetic Agents: Azimexon and Tuftsin.- Effects of BM 12,531 (Azimexon) on in Vitro Lymphocyte and Macrophage Proliferation.- Comparative Evaluation of the Tumor Inhibitory and Antibacterial Activity of Solubilized and Particulate Glucan.- Mechanism of the Inhibitory Effect of Levan on Experimental Tumors.- Lynestrenol: A Progesterone like Agent with Immunostimulatory Properties.- Chemotherapy Immunogenicity.- Selective Imbalances of Cellular Immune Responses by Adriamycin.- The Heterogeneity of the Interaction Between Cancer Chemotherapeutic Agents and Host Resistance Mechanisms.- Endotoxin-Induced Tumor Necrosis Factor.- Antimicrobial Resistance Enhancing Activity of Tumor Necrosis Serum Factor Induced by Endotoxin in BCG-TreatedMice.- Tumor-Necrotizing Serum Production by Administration of BCG + Pseudomonas: Its Application in Treatment of Fibrosarcoma in Mice.- Usefulness of the Results of Studies on the Antitumor Effects of Interferon in Animals to Interferon-Therapy of Patients.- DNA, Liposomes, and Proteins as Carriers for Antitumoral Drugs.- Antibodies as Carriers for Oncostatic Materials.- Pulmonary Localization of Intravenously Injected Liposomes.- Erythrocytes and Lymphocytes as Drug Carrier Systems: Techniques for Entrapment of Drugs in Living Cells.- Chemo- and Immunopharmacology: The Reality and the Horizons of Cancer Treatment.